Nasalgen IP

Company: Intervet/Merck Animal Health

Bovine Rhinotracheitis-Parainfluenza 3 Vaccine

Modified Live Virus

Cattle Vaccine

Nasalgen IP Indications

Nasalgen^® IP vaccine is for the vaccination of healthy cattle 5 months of age or older as an aid in the prevention of disease caused by infectious bovine rhinotracheitis and parainfluenza 3 virus.

Dosage and Administration

Aseptically rehydrate Nasalgen^® IP vaccine with the enclosed diluent. Administer 2 mL into one nostril or 1 mL into each nostril for a 2 mL dose, using a separate disposable cannula for each animal.

Nasalgen^® IP vaccine is safe for use in pregnant cows or in calves nursing pregnant cows. Calves vaccinated under 5 months of age should be revaccinated at 5 months of age or weaning.

FOR INTRANASAL USE ONLY

FOR ANIMAL USE ONLY

Nasalgen IP Caution

Store at 2°-7°C (35°-45°F). Use entire contents when first opened. Do not use chemical disinfectants to sterilize syringes, needles or cannulas. Burn container and all unused contents. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use, treat with epinephrine. Contains gentamicin as a preservative.

Precaution: This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, NE 68103 USA

U.S. Veterinary License No. 165A

1 800 521-5767

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047133.4